| Name | Title | Contact Details |
|---|---|---|
Andrew Pipp |
Vice President Information Technology | Profile |
Andrew Pipp |
Chief Information Officer, Security Officer | Profile |
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
The company, founded in 1992 by former nurse and inventor Tom Kruse, is based in Sarasota, Florida.
Vascular Therapies, Inc., a privately-held late-stage biopharmaceutical company, is developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.
We dont just treat cancer, we treat people. You can count on us to put you first and provide the most advanced treatments. Lets beat this together.
Developing HIV prevention products for women worldwide